Results 121 to 130 of about 8,601 (210)

Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma. [PDF]

open access: yesBlood Adv
Charton E   +27 more
europepmc   +1 more source

Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma. [PDF]

open access: yesFront Oncol
Amaducci E   +9 more
europepmc   +1 more source

Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma. [PDF]

open access: yesBlood Adv
Darnell EP   +11 more
europepmc   +1 more source

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial. [PDF]

open access: yesNat Cancer
Strati P   +14 more
europepmc   +1 more source

Editorial: Benign paroxysmal positional vertigo

open access: yesFrontiers in Neurology
Anita Bhandari   +4 more
doaj   +1 more source

Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS. [PDF]

open access: yesBlood Adv
Wang WL   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy